P20‐1 
A new locus for autosomal dominant Charcot‐Marie‐Tooth disease type 2 (CMT2L) maps to chromosome 12Q24

W. Luo,K. Xia,O. V. Evgrafov
DOI: https://doi.org/10.1046/j.1474-1644.2003.p20_01.x
2004-01-01
Journal of Neurochemistry
Abstract:Charcot-Marie-Tooth Disease (CMT) is one of the most common inherited neurological disorders with a prevalence estimated at 1/2500. The axonal form of this disorder is referred to as CharcotMarie-Tooth type 2 disease (CMT2). Recently a large Chinese family with CMT2 was found in the Hunan and Hubei provinces of China. The known loci of CMT1A, CMT2D, CMT1B (the same locus also responsible for CMT2I and CMT2J), CMT2A, CMT2E and CMT2F were excluded by linkage analysis. The results of a genome-wide screening demonstrated linkage to a locus on chromosome 12q24, over a 6.8-cM interval between markers D12S366 and D12S1611. A maximal two-point LOD score of 6.35 and multipoint LOD score of 8.48 for marker D12S76 at recombination fraction (h) of 0 strongly support linkage to this locus. Thus CMT2 neuropathy in this family represents a novel genetic entity designated by us as CMT2L.
What problem does this paper attempt to address?